Acadia Healthcare Company, Inc. (ACHC)
Acadia Healthcare Company, Inc. is a leading provider of behavioral healthcare services in the United States and Puerto Rico. The company operates a network of inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics.
Company Overview
Acadia Healthcare offers a compelling investment opportunity within the growing behavioral healthcare market, boasting a wide network of facilities and a proven track record, despite its modest profit margin, presenting a chance to capitalize on increasing demand for mental health services.
Investment Thesis
Acadia Healthcare presents a compelling investment opportunity due to the increasing demand for behavioral healthcare services, driven by rising awareness of mental health issues and limited access to treatment. With a P/E ratio of 11.26, Acadia appears undervalued compared to its peers, suggesting potential for capital appreciation. The company's extensive network of facilities and diverse service offerings position it to capitalize on this growing market. Key value drivers include continued expansion of its facility network, improved operational efficiencies, and strategic acquisitions. The company's gross margin of 81.4% demonstrates its ability to maintain profitability, while its beta of 0.88 indicates lower volatility compared to the broader market. Investors should consider Acadia's growth catalysts, such as favorable regulatory changes and increasing reimbursement rates for behavioral healthcare services.
Key Highlights
- Acadia Healthcare operates a network of 238 behavioral healthcare facilities, providing a wide geographic reach.
- The company's gross margin of 81.4% highlights its efficient cost management and pricing strategies.
- Acadia's P/E ratio of 11.26 suggests potential undervaluation compared to industry peers.
- The company's beta of 0.88 indicates lower volatility compared to the overall market.
- Acadia's profit margin of 3.3% reflects opportunities for improvement through operational efficiencies.
Competitors
Strengths
- Extensive network of behavioral healthcare facilities.
- Diverse service offerings.
- Strong reputation for quality care.
- Experienced management team.
Weaknesses
- Modest profit margin.
- High debt levels.
- Dependence on government reimbursement rates.
- Exposure to regulatory changes.
Catalysts
- Ongoing: Increasing demand for behavioral healthcare services.
- Upcoming: Potential for favorable regulatory changes.
- Ongoing: Expansion of telehealth services.
- Upcoming: Strategic acquisitions to expand market reach.
Risks
- Potential: Increased competition in the behavioral healthcare market.
- Ongoing: Changes in government reimbursement policies.
- Potential: Economic downturn impacting patient volumes.
- Ongoing: Regulatory scrutiny and compliance requirements.
- Potential: Litigation and malpractice claims.
Growth Opportunities
- Expansion of Telehealth Services: Acadia can leverage the growing adoption of telehealth to expand its reach and improve access to care, particularly in underserved areas. The telehealth market is projected to reach $30 billion by 2028, presenting a significant growth opportunity. By investing in telehealth infrastructure and training, Acadia can attract new patients and improve patient outcomes, while also reducing costs associated with traditional in-person care. This expansion can be achieved within the next 2-3 years.
- Strategic Acquisitions: Acadia can continue to pursue strategic acquisitions to expand its geographic footprint and service offerings. The behavioral healthcare market remains fragmented, providing opportunities to acquire smaller regional players and integrate them into Acadia's network. These acquisitions can provide access to new markets, specialized treatment programs, and experienced clinical staff. Acadia has a proven track record of successful acquisitions, which can be replicated in the coming years.
- Development of Specialty Treatment Programs: Acadia can develop and expand its specialty treatment programs to address specific patient needs, such as eating disorders, trauma, and co-occurring disorders. These programs can attract patients seeking specialized care and differentiate Acadia from its competitors. By investing in specialized training and resources, Acadia can establish itself as a leader in these niche areas. Development of these programs can begin immediately and expand over the next 5 years.
- Partnerships with Payers and Healthcare Systems: Acadia can forge partnerships with payers and healthcare systems to improve access to care and streamline the referral process. These partnerships can involve value-based care arrangements, integrated care models, and shared risk agreements. By collaborating with payers and healthcare systems, Acadia can improve patient outcomes, reduce costs, and increase its market share. These partnerships can be established within the next 1-2 years.
- Focus on Outpatient Services: Acadia can expand its outpatient services to provide a continuum of care for patients transitioning from inpatient settings. Outpatient services can include individual therapy, group therapy, medication management, and intensive outpatient programs. By offering a comprehensive range of outpatient services, Acadia can improve patient outcomes, reduce readmission rates, and generate recurring revenue. Expansion of outpatient services can be phased in over the next 3-5 years.
Opportunities
- Expansion of telehealth services.
- Strategic acquisitions.
- Development of specialty treatment programs.
- Partnerships with payers and healthcare systems.
Threats
- Increased competition.
- Changes in reimbursement policies.
- Economic downturn.
- Negative publicity.
Competitive Advantages
- Established network of facilities provides a wide geographic reach.
- Strong reputation for providing high-quality care.
- Diverse service offerings cater to a wide range of patient needs.
- Relationships with payers and healthcare systems.
- Economies of scale in facility operations.
About
Founded in 2005 and headquartered in Franklin, Tennessee, Acadia Healthcare Company, Inc. has rapidly grown to become a significant player in the behavioral healthcare industry. The company provides a comprehensive suite of services, including inpatient psychiatric care, specialty treatment for substance abuse and eating disorders, residential treatment programs, and outpatient therapy. Acadia operates a network of 238 behavioral healthcare facilities with approximately 10,600 beds as of March 31, 2022, strategically located across the United States and Puerto Rico. Acadia's facilities cater to a diverse patient population, addressing a wide spectrum of mental health and addiction-related needs. The company's growth strategy has involved both organic expansion and strategic acquisitions, allowing it to broaden its geographic footprint and service offerings. By focusing on providing high-quality, evidence-based care, Acadia has established a strong reputation within the behavioral healthcare community, positioning itself as a trusted provider for patients, families, and referral sources. Acadia continues to adapt to the evolving healthcare landscape by expanding its telehealth capabilities and integrating innovative treatment modalities to improve patient outcomes and access to care.
What They Do
- Operate inpatient psychiatric hospitals.
- Provide specialty treatment facilities for addiction and mental health.
- Offer residential treatment centers for long-term care.
- Manage outpatient clinics for therapy and counseling.
- Deliver behavioral healthcare services in the United States and Puerto Rico.
- Provide treatment for mental health disorders, substance abuse, and co-occurring disorders.
- Offer individualized treatment plans tailored to patient needs.
- Employ a team of psychiatrists, therapists, and other healthcare professionals.
Business Model
- Generate revenue through patient fees and insurance reimbursements.
- Operate a network of behavioral healthcare facilities.
- Provide a range of services, including inpatient, outpatient, and residential treatment.
- Focus on providing high-quality, evidence-based care.
FAQ
What does Acadia Healthcare Company, Inc. do?
Acadia Healthcare Company, Inc. operates a network of behavioral healthcare facilities, providing a range of services, including inpatient psychiatric care, specialty treatment for substance abuse and eating disorders, residential treatment programs, and outpatient therapy. The company generates revenue through patient fees and insurance reimbursements. Acadia focuses on providing high-quality, evidence-based care to individuals with mental health disorders and substance abuse issues. As of March 31, 2022, it operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds.
Is ACHC stock a good buy?
Acadia Healthcare (ACHC) presents a mixed investment profile. The increasing demand for behavioral healthcare services and the company's established network of facilities are positive factors. However, the modest profit margin of 3.3% and exposure to regulatory changes are potential concerns. With a P/E ratio of 11.26, ACHC may be undervalued compared to its peers, but investors should carefully consider the risks and growth opportunities before making a decision. Continued expansion of services and strategic acquisitions could drive future growth.
What are the main risks for ACHC?
Acadia Healthcare faces several risks, including increased competition in the behavioral healthcare market, changes in government reimbursement policies, and the potential for an economic downturn to impact patient volumes. Regulatory scrutiny and compliance requirements also pose ongoing challenges. Litigation and malpractice claims are inherent risks in the healthcare industry. These risks could negatively impact Acadia's financial performance and growth prospects. Investors should carefully assess these risks before investing in ACHC.
Industry Context
Acadia Healthcare operates within the growing behavioral healthcare industry, which is experiencing increased demand due to rising awareness of mental health issues and substance abuse. The market is characterized by a fragmented landscape with a mix of large national providers and smaller regional players. Acadia competes with other publicly traded companies, such as Universal Health Services (UHS) and Community Health Systems (CYH), as well as numerous private providers. The industry is subject to evolving regulatory requirements and reimbursement policies, which can impact profitability. The increasing adoption of telehealth and integrated care models presents both opportunities and challenges for providers in this space.
Key Customers
- Individuals with mental health disorders.
- Individuals struggling with substance abuse.
- Families seeking treatment for loved ones.
- Healthcare providers referring patients for behavioral healthcare services.
- Insurance companies covering behavioral healthcare costs.
Financials
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $852M | $36M | $0.00 |
| Q2 2025 | $869M | $30M | $0.00 |
| Q1 2025 | $771M | $8M | $0.00 |
| Q4 2024 | $774M | $33M | $0.00 |
Source: Company filings
Chart & Info
Price Chart
Acadia Healthcare Company, Inc. (ACHC) stock price: $14.28 (-0.01, -0.07%)
Why Bull
- •Recent insider buying indicates confidence in Acadia's recovery strategy, suggesting leadership believes in future growth.
- •Community sentiment has shifted positively, with discussions highlighting the company's potential in the mental health sector.
- •Analysts have noted Acadia's expansion efforts and partnerships that could enhance service offerings and market reach.
- •Increased focus on mental health services post-pandemic has positioned Acadia favorably in a growing industry.
Why Bear
- •Concerns persist about regulatory challenges in the healthcare sector, which could impact operational flexibility.
- •Recent bearish sentiment in forums reflects worries over potential staffing shortages affecting service quality.
- •Market perception is cautious due to economic uncertainties that could affect healthcare spending.
- •Some analysts question the sustainability of growth given competitive pressures in the mental health space.
Latest News
-
Acadia Healthcare, Hims & Hers Health, RadNet, Halozyme Therapeutics, and Privia Health Shares Are Soaring, What You Need To Know
StockStory · Feb 13, 2026
-
'Investor Einhorn said he bought Peloton again on this latest dip. Here's what else he's buying'- CNBC Pro
benzinga · Feb 11, 2026
-
Elastic NV, Acadia Healthcare, and More Stocks See Action From Activist Investors
Barrons.com · Jan 31, 2026
-
Earnings Scheduled For November 5, 2025
benzinga · Nov 5, 2025
Technical Analysis
Rationale
AI-generated technical analysis for ACHC including trend direction, momentum, and pattern recognition.
What to Watch
Key support and resistance levels, volume signals, and upcoming events.
Risk Management
Position sizing, stop-loss levels, and risk-reward assessment.
Community
Discussion
Share your analysis and discuss Acadia Healthcare Company, Inc. (ACHC) with other investors. Log in to post.
Sentiment
Community sentiment and discussion activity for ACHC.
Make a Prediction
Set your price target for Acadia Healthcare Company, Inc. (ACHC), choose a timeframe, and track your prediction accuracy.
Current price: $14.28
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ACHC.
Price Targets
Wall Street price target analysis for ACHC.
Insider Flow (30d)
MoonshotScore
Score Factors
- Revenue Growth 4/100
- Gross Margin 8/100
- Operating Leverage 4/100
- Cash Runway 5/100
- R&D Intensity 5/100
- Insider Activity 6/100
- Short Interest 5/100
- Price Momentum 0/100
- News Sentiment 5/100
What does this score mean?
The MoonshotScore rates ACHC's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Latest News
Acadia Healthcare, Hims & Hers Health, RadNet, Halozyme Therapeutics, and Privia Health Shares Are Soaring, What You Need To Know
'Investor Einhorn said he bought Peloton again on this latest dip. Here's what else he's buying'- CNBC Pro
Elastic NV, Acadia Healthcare, and More Stocks See Action From Activist Investors
Earnings Scheduled For November 5, 2025
Frequently Asked Questions
What does Acadia Healthcare Company, Inc. do?
Acadia Healthcare Company, Inc. operates a network of behavioral healthcare facilities, providing a range of services, including inpatient psychiatric care, specialty treatment for substance abuse and eating disorders, residential treatment programs, and outpatient therapy. The company generates revenue through patient fees and insurance reimbursements. Acadia focuses on providing high-quality, evidence-based care to individuals with mental health disorders and substance abuse issues. As of March 31, 2022, it operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds.
Is ACHC stock a good buy?
Acadia Healthcare (ACHC) presents a mixed investment profile. The increasing demand for behavioral healthcare services and the company's established network of facilities are positive factors. However, the modest profit margin of 3.3% and exposure to regulatory changes are potential concerns. With a P/E ratio of 11.26, ACHC may be undervalued compared to its peers, but investors should carefully consider the risks and growth opportunities before making a decision. Continued expansion of services and strategic acquisitions could drive future growth.
What are the main risks for ACHC?
Acadia Healthcare faces several risks, including increased competition in the behavioral healthcare market, changes in government reimbursement policies, and the potential for an economic downturn to impact patient volumes. Regulatory scrutiny and compliance requirements also pose ongoing challenges. Litigation and malpractice claims are inherent risks in the healthcare industry. These risks could negatively impact Acadia's financial performance and growth prospects. Investors should carefully assess these risks before investing in ACHC.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Data provided for informational purposes only.